Tandem Diabetes Care (TNDM) Net Income towards Common Stockholders Growth (1y) (2014 - 2026)
Powered by 
Analysis
Tandem Diabetes Care (TNDM) Net Income towards Common Stockholders Growth (1y) (2014 - 2026) Analysis & Trends
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Net Income Growth (1y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 179.84 Bn | 174.23 Bn | 7.27 Bn | -47.84% |
| 2 | Intuitive Surgical | 128.02 Bn | 122.81 Bn | 1.96 Bn | 23.94% |
| 3 | Medtronic | 117.28 Bn | 108.46 Bn | 6.34 Bn | 41.36% |
| 4 | Stryker | 103.92 Bn | 100.44 Bn | 4.50 Bn | 44.34% |
| 5 | Boston Scientific | 63.51 Bn | 62.97 Bn | 3.85 Bn | 13.80% |
| 6 | Edwards Lifesciences | 49.96 Bn | 45.70 Bn | 1.35 Bn | -27.18% |
| 7 | Alcon | 32.86 Bn | 31.40 Bn | 1.68 Bn | - |
| 8 | Dexcom | 32.25 Bn | 30.30 Bn | 830.00 Mn | 38.54% |
| 9 | Steris | 20.74 Bn | 20.26 Bn | 684.20 Mn | 12.92% |
| 10 | Tandem Diabetes Care | 1.26 Bn | 808.29 Mn | 144.78 Mn | 59.52% |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 59.52% |
| Mar 31, 2026 | 84.37% |
| Dec 31, 2025 | -170.06% |
| Sep 30, 2025 | 9.07% |
| Jun 30, 2025 | -69.89% |
| Mar 31, 2025 | -205.65% |
| Dec 31, 2024 | 102.59% |
| Sep 30, 2024 | 29.46% |
| Jun 30, 2024 | 13.79% |
| Mar 31, 2024 | 65.51% |
| Dec 31, 2023 | -89.03% |
| Sep 30, 2023 | 32.69% |
| Jun 30, 2023 | -136.83% |
| Mar 31, 2023 | -742.00% |
| Dec 31, 2022 | -247.28% |
| Sep 30, 2022 | -951.95% |
| Jun 30, 2022 | -477.65% |
| Mar 31, 2022 | -189.49% |
| Dec 31, 2021 | -36.68% |
| Sep 30, 2021 | 160.90% |